The associations of nocturia with hypertension and anti-hypertensive agents (AHTs) remain to be validated.
This cross-sectional study examined whether blood pressure and/or frequently used classes of AHTs had consistent associations with nocturia.
A total of 418 male patients aged ≥ 40 years were retrospectively assessed in terms of the International Prostate Symptom Score (IPSS), prescription medications, and blood pressure. Nocturia was evaluated using item 7 of the IPSS, and two or more episodes of nocturia per night was considered to indicate clinically important nocturia.
Patients taking calcium channel blockers (CCBs), but not other AHTs, experienced more episodes of nocturia than patients not taking AHTs (1.77 ± 1.07, 1.90 ± 1.19, and 1.48 ± 0.98 in CCBs alone, CCBs + other AHTs, and other AHTs alone, vs. 1.35 ± 1.08 in not taking AHTs; p = 0.014, p < 0.0001, and p = 0.91, respectively), whereas there was no significant difference in the number of nocturia episodes between patients with elevated and normal blood pressure. In multivariate analysis, CCB (odds ratio (OR) = 2.68, p < 0.0001) and age (OR = 1.06, p < 0.0001) were independently associated with clinically important nocturia.
CCB was associated with nocturia, while AHTs other than CCBs and elevated blood pressure were not.
Journal of clinical medicine. 2021 Apr 09*** epublish ***
Satoshi Washino, Yusuke Ugata, Kimitoshi Saito, Tomoaki Miyagawa
Department of Urology, Jichi Medical University Saitama Medical Center, Saitama 330-8503, Japan., Department of Cardiology, Jichi Medical University Saitama Medical Center, Saitama 330-8503, Japan.